← Back to Search
Therapeutic Nanoparticles And Their Targeted Delivery Applications
Abuzer Alp Yetisgin, Sibel Çetinel, Merve Zuvin, Ali Koşar, O. Kutlu
Published 2020 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
Nanotechnology offers many advantages in various fields of science. In this regard, nanoparticles are the essential building blocks of nanotechnology. Recent advances in nanotechnology have proven that nanoparticles acquire a great potential in medical applications. Formation of stable interactions with ligands, variability in size and shape, high carrier capacity, and convenience of binding of both hydrophilic and hydrophobic substances make nanoparticles favorable platforms for the target-specific and controlled delivery of micro- and macromolecules in disease therapy. Nanoparticles combined with the therapeutic agents overcome problems associated with conventional therapy; however, some issues like side effects and toxicity are still debated and should be well concerned before their utilization in biological systems. It is therefore important to understand the specific properties of therapeutic nanoparticles and their delivery strategies. Here, we provide an overview on the unique features of nanoparticles in the biological systems. We emphasize on the type of clinically used nanoparticles and their specificity for therapeutic applications, as well as on their current delivery strategies for specific diseases such as cancer, infectious, autoimmune, cardiovascular, neurodegenerative, ocular, and pulmonary diseases. Understanding of the characteristics of nanoparticles and their interactions with the biological environment will enable us to establish novel strategies for the treatment, prevention, and diagnosis in many diseases, particularly untreatable ones.
This paper references
Drug transport across the blood-brain barrier
J. M. Bree (2005)
Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.
S. Cohen (2013)
Protracted elimination of gold nanoparticles from mouse liver.
E. Sadauskas (2009)
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
M. J. Ernsting (2013)
Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis
J. Falconer (2018)
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
Y. Fujiwara (2019)
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar ud Din (2017)
Definitions of terms relating to the structure and processing of sols, gels, networks, and inorganic-organic hybrid materials (IUPAC Recommendations 2007)
J. Alemán (2007)
Clinical Potential of Quantum Dots
A. M. Iga (2007)
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
Strong synergy of heat and modulated electromagnetic field in tumor cell killing
G. Andocs (2009)
Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer.
T. Liu (2014)
Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.
S. Zhang (2010)
Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes.
A. Haeri (2017)
Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.
Sampath C Abeylath (2008)
Current advances in self-assembled nanogel delivery systems for immunotherapy.
Y. Tahara (2015)
Neuroprotective e ff ects of novel phosphatidylglycerol - based phospholipids in the 6 - hydroxydopamine model of Parkinson ’ s disease
C. F. Xia (2008)
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate
Liuxi Chen (2016)
A quantum spin transducer based on nanoelectromechanical resonator arrays
P. Rabl (2010)
In vivo monitoring of distributional transport kinetics and extravasation of quantum dots in living rat liver.
Cheng-Kuan Su (2013)
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
T. Walsh (1999)
Nano-diamond films produced from CVD of camphor
K. Chakrabarti (1998)
Products to market
L. J. Burbidgh (1993)
Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Liangliang Dai (2016)
Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation.
A. Azeem (2012)
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
S. Laserra (2015)
Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
N. Liptrott (2018)
Polymeric micelles as drug delivery vehicles
Z. Ahmad (2014)
Nanodiamonds for In Vivo Applications.
KiranJ. van der Laan (2018)
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
J. Y. Yhee (2016)
Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
M. Chidambaram (2011)
Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate.
M. T. Kim (2014)
Transport of drugs across the blood-brain barrier by nanoparticles.
Stefanie Wohlfart (2012)
A Clinical Study to Measure the Effect of OP-101 after Being Administered Subcutaneous in Healthy Volunteers
Azo-functionalized Fe3O4 nanoparticles: a near-infrared light triggered drug delivery system for combined therapy of cancer with low toxicity.
Ling Chen (2016)
Novel approach for preparing nontoxic stealth microspheres for drug delivery
P. Angra (2011)
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes (2017)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
Applications of Nanodiamonds in the Detection and Therapy of Infectious Diseases
Eva Torres Sangiao (2019)
Magnetic hyperthermia therapy: An emerging modality of cancer treatment in combination with radiotherapy
Neena G. Shetake (2016)
Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer.
Ruinan Yang (2017)
Cytotoxicity studies of selected cadmium-based quantum dots on 2D vs. 3D cell cultures
I. Grabowska-Jadach (2018)
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
A. Manzoor (2012)
Nanoparticles in the clinic: An update
Aaron C. Anselmo (2019)
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
P. Chelle (2019)
Stavudine‐loaded mannosylated liposomes: in‐vitro anti‐HIV‐I activity, tissue distribution and pharmacokinetics
M. Garg (2006)
Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model
R. Huang (2010)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe (2015)
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
S. O'brien (2013)
Antiviral activity of nano carbon fullerene lipidosome against influenza virus in vitro
Hong Ji 季 虹 (2008)
Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).
Z. Marković (2008)
Engineering Virus-like Particles for Antigen and Drug Delivery.
B. D. Hill (2018)
Therapeutic approaches to Alzheimer's disease.
Hans-Wolfgang Klafki (2006)
Protein-based nanoparticles: From preparation to encapsulation of active molecules.
Mohamad Tarhini (2017)
Size-Dependent Endocytosis of Nanoparticles.
Sulin Zhang (2009)
Nanobiomaterials’ applications in neurodegenerative diseases
Daniela Silva Adaya (2017)
Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.
N. Shaik (2008)
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants.
P. Sendi (2009)
Applications of nanoparticle systems in drug delivery technology
S. A. Rizvi (2018)
Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C Bell (2018)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
Stimuli-responsive nanocarriers for drug
S. Mura (2013)
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts.
T. Boulikas (2004)
Self-assembling protein nanoparticles in the design of vaccines
Jacinto López-Sagaseta (2016)
Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
I. Neeland (2018)
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
M. Bondì (2010)
Exosome Theranostics: Biology and Translational Medicine
Chuanjiang He (2018)
Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria.
L. Wang (2014)
Onivyde for the therapy of multiple solid tumors
H. Zhang (2016)
CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation.
Y. Lu (2016)
Liposomes as nanomedical devices
G. Bozzuto (2015)
Development of Glatopa ( R ) ( Glatiramer Acetate ) : The First FDA - Approved Generic Disease - Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C. Bell (2018)
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
Gold nanoparticles in ophthalmology
F. Masse (2019)
Crystal structure of paliperidone palmitate (INVEGA SUSTENNA®), C39H57FN4O4
J. Kaduk (2017)
Production, surface modification and biomedical applications of nanodiamonds: A sparkling tool for theranostics.
Hussain Tinwala (2019)
PEGylated-PLGA microparticles containing VEGF for long term drug delivery.
T. Simón-Yarza (2013)
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Y. Luo (2015)
Drug targeting using solid lipid nanoparticles.
E. Rostami (2014)
Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
Kevin Pham (2016)
Nanodiamonds as Platforms for Biology and Medicine
H. Man (2013)
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer.
V. S. Madamsetty (2019)
Evaluation of the Nanosphere Verigene Gram-Positive Blood Culture Assay with the VersaTREK Blood Culture System and Assessment of Possible Impact on Selected Patients
S. Beal (2013)
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.
P. Mróz (2007)
Aptamer-conjugated gold nanorod for photothermal ablation of epidermal growth factor receptor-overexpressed epithelial cancer
J. Choi (2014)
Macrophage response to chitosan/poly-(γ-glutamic acid) nanoparticles carrying an anti-inflammatory drug
R. Gonçalves (2015)
Albumin-bound paclitaxel: a next-generation taxane
W. Gradishar (2006)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
A. Basso (2008)
Doxorubicin-conjugated pH-responsive gold nanorods for combined photothermal therapy and chemotherapy of cancer
J. Chen (2018)
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
V. Junyaprasert (2015)
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
M. Yu (2012)
Current applications of nanoparticles in infectious diseases.
H. Zazo (2016)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
B. Wilson (2008)
Silica based hybrid materials for drug delivery and bioimaging
Elnaz Bagheri (2018)
Exosomes: cell-created drug delivery systems
Anastasia Familtseva (2019)
Exosome-based strategies for Diagnosis and Therapy.
L. Urbanelli (2015)
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
Fatemeh Farjadian (2019)
Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry.
Natalie Weder (2014)
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
A macrophage-nanozyme delivery system for Parkinson's disease.
E. Batrakova (2007)
Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In Vivo
Q. Zhang (2014)
Properties of AdeABC and AdeIJK Efflux Systems of Acinetobacter baumannii Compared with Those of the AcrAB-TolC System of Escherichia coli
E. Sugawara (2014)
Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative damage in an MPP+‐induced cellular model of Parkinson's disease
X. Cai (2008)
Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
Q. Pan (2015)
Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications
Wei Wu (2018)
Quantum Dots Elicit Hepatotoxicity through Lysosome-Dependent Autophagy Activation and Reactive Oxygen Species Production
J. Fan (2018)
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
H. Lim (2018)
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Warangkana Lohcharoenkal (2014)
The antimicrobial activity of nanoparticles: present situation and prospects for the future
L. Wang (2017)
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.
Howard E. Gendelman (2015)
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
Antimicrobial activity and cytocompatibility of silver nanoparticles coated catheters via a biomimetic surface functionalization strategy
K. Wu (2015)
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data.
S. Doktorovová (2014)
Certolizumab pegol for the treatment of rheumatoid arthritis
I. Modesto (2011)
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer.
V. S. Madamsetty (2019)
Cationic fullerenes are effective and selective antimicrobial photosensitizers.
G. Tegos (2005)
Physicochemical and Biological Examination of Two Glatiramer Acetate Products
A. Komlosh (2019)
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
Z. Chen (2014)
Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease
S. Crotty (2008)
A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
Zamanzima Mazibuko (2015)
Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.
Shyh-Dar Li (2010)
Biomedical applications of bisphosphonates.
E. Giger (2013)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.
Y. Tu (2015)
Recent Drug Delivery Systems for Treatment of Glaucoma
Noha S El-Salamounia (2016)
Lipoplatin Formulation Review Article
G. Stathopoulos (2012)
Near infrared light-responsive and injectable supramolecular hydrogels for on-demand drug delivery.
X. Wang (2016)
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
Y. H. Lim (2016)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
J. Fang (2011)
Drug delivery to the eye: what benefits do nanocarriers offer?
R. Joseph (2017)
Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles
K. Akiyoshi (1993)
Protein nanoparticles for therapeutic protein delivery.
L. Herrera Estrada (2015)
In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
K. Letchford (2009)
Enhanced loading and controlled release of rhBMP-2 in thin mineralized collagen coatings with the aid of chitosan nanospheres and its biological evaluations.
Ziqiang Kong (2014)
Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
C. Puglia (2015)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing
O A Cornely
Therapeutic applications of Nanorobots-Respirocytes and Microbivores
P S Shabnashmi (2016)
Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
Y. Liu (2015)
Shape and aggregation control of nanoparticles: not shaken, not stirred.
D. Li (2006)
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
Targeted Nanodelivery of Drugs and Diagnostics.
M. Phillips (2010)
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment.
K. Venkatakrishnan (2014)
Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery
R. Tong (2012)
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
S. de Castro (2018)
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
T. Dutta (2008)
Quantum dots in biology and medicine
R. E. Bailey (2004)
Carbon Nanotubes: Potential Benefits and Risks of Nanotechnology in Nuclear Medicine
R. Reilly (2007)
Cellular mechanisms of multidrug resistance of tumor cells.
A. Stavrovskaya (2000)
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS
Lipa K Shah (2006)
Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.
M. B. de Jesus (2015)
A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions
J. Zhou (2018)
Exosome Research and Co-culture Study.
T. Shimasaki (2018)
Quantum dots in imaging, drug delivery and sensor applications
C. Matea (2017)
Nanotechnology-Based Approaches for Ophthalmology Applications: Therapeutic and Diagnostic Strategies
Mehdi Ghaffari Sharaf (2014)
Basic concepts and recent advances in nanogels as carriers for medical applications
I. Neamţu (2017)
Polymeric nanoparticles: A study on the preparation variables and characterization methods.
Carina Crucho (2017)
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol
P Chelle (2020)
Updates in the medical management of Parkinson disease
H. Fernandez (2012)
Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.
B. Mishra (2010)
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Shixian Lv (2014)
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
S. Jahan (2017)
Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial.
A. Kharlamov (2017)
Bone Regeneration from PLGA Micro-Nanoparticles
I. Ortega-Oller (2015)
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
O. Cornely (2007)
Application of liposomes in medicine and drug delivery
H. Daraee (2016)
Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge
Gelareh Arzani (2015)
Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
R. Löbenberg (1998)
Bacteriolysis by vancomycin-conjugated acryl nanoparticles and morphological component analysis
N. Shimizu (2014)
Gene transfer into guinea pig cochlea using adeno‐associated virus vectors
M. Konishi (2008)
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Y. Nakamura (2016)
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
Using exosomes, naturally-equipped nanocarriers, for drug delivery.
E. Batrakova (2015)
Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
Hye-min Kim (2018)
The effects of engineered nanoparticles on pulmonary immune homeostasis
R. Mohamud (2014)
Liposomes as nanovaccine delivery systems.
K. A. Ghaffar (2014)
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Ela Markovsky (2014)
Enhanced apatite-forming ability and cytocompatibility of porous and nanostructured TiO2/CaSiO3 coating on titanium.
H. Hu (2013)
pH-responsive polymer-drug conjugates: Design and progress.
X. Pang (2016)
Nano based drug delivery systems: recent developments and future prospects
J. Patra (2018)
DENDRIMER APPLICATIONS – A REVIEW
H.N.Patel and Dr. P.M.Patel (2013)
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
T. Walsh (1999)
The intersection of nanotechnology, drug development, and personalized medicine
D Ho (2015)
Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.
E. Turos (2007)
Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time
A. Fabiano (2015)
Nanotechnology Applications for Glaucoma
Sibel Çetinel (2016)
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
A. Neves (2013)
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc (2019)
Maxillary sinus floor augmentation using a nano-crystalline hydroxyapatite silica gel: case series and 3-month preliminary histological results.
L. Canullo (2012)
Utilising inorganic nanocarriers for gene delivery.
X. J. Loh (2016)
UV-enhanced cytotoxicity of CdTe quantum dots in PANC-1 cells depend on their size distribution and surface modification.
Shuquan Chang (2013)
Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island.
S. Chakraborti (2014)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
T. Boulikas (2009)
Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Qianhua Feng (2017)
An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy.
Yuxia Pei (2018)
Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.
Joshua Buse (2010)
Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hao-jui Hsu (2017)
Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells
Hongxin Shen (2015)
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice.
Ashwin Bhirde (2010)
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
C. Tapeinos (2017)
Synthesis, characterization, and biological properties of composites of hydroxyapatite and hexagonal boron nitride.
Semra Unal (2018)
EquivaBone Osteoinductive Bone Graft Substitute
MSC-exosome: A novel cell-free therapy for cutaneous regeneration.
P. Wu (2018)
Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.
S. Davis (1997)
The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
Penny A. MacDonald (2011)
The Use of Liposomes for Constructing Cell Models
T. Oberholzer (2002)
Nanotechnology for delivery of drugs and biomedical applications.
S. Leucuţa (2010)
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Shrinidh A Joshi (2010)
Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs.
Jafar Ezzati Nazhad Dolatabadi (2015)
Nanogel—an advanced drug delivery tool: Current and future
A. Sharma (2016)
K. Lyseng-Williamson (2012)
Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells
Shintaro Warabi (2004)
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)–vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC)
F. Farhat (2010)
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
A. Cuenca (2006)
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
S. Weber (2014)
Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic
S. Hussein-Al-Ali (2014)
Sensors and regulators of intracellular pH
J. Casey (2010)
Weak Bond-Based Injectable and Stimuli Responsive Hydrogels for Biomedical Applications.
Xiaochu Ding (2017)
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Caixia Fan (2011)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
D. Ho (2015)
Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma.
M. M. Ibrahim (2015)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
C. Saraiva (2016)
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy.
L. Tian (2016)
Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer
Priyanka Singh (2018)
Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
G. Abrego (2015)
Site-specific antibody drug conjugates for cancer therapy
S. Panowski (2014)
Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Qianhua Feng (2016)
Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
T. Yamashita (2018)
Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot–lipid complex
D. Shao (2014)
In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus.
Subhankari Prasad Chakraborty (2012)
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C. Bell (2018)
Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification
Jacob W Shreffler (2019)
Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
Fang Chen (2018)
Nanotechnology-based strategies for treatment of ocular disease
Yuhua Weng (2017)
Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
F. R. Formiga (2010)
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications
S. Chandrasekhar (2013)
Synthesis and application of nanostructured calcium phosphate ceramics for bone regeneration.
D. Alves Cardoso (2012)
Investigation of endosome and lysosome biology by ultra pH‐sensitive nanoprobes☆
Chensu Wang (2017)
Protein-based nanoparticles in cancer vaccine development.
M. Neek (2019)
Polymeric nanoparticles for enhancing antiretroviral drug therapy.
T. Govender (2008)
Structural Biology of the TNFalpha Antagonists Used in the Treatment of Rheumatoid Arthritis
H Lim (2018)
Novel methods for liposome preparation.
Yogita P Patil (2014)
Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use
Rathapon Asasutjarit (2015)
Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
J. Bullivant (2013)
Targeting of 3′-Azido 3′-Deoxythymidine (AZT)-Loaded Poly(Isohexylcyanoacrylate) Nanospheres to the Gastrointestinal Mucosa and Associated Lymphoid Tissues
Assia Dembri (2004)
Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
Y. Choi (2017)
Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases.
Sonia Gera (2017)
Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.
D. Bharali (2005)
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
Antimycobacterial activity of ionic fullerene derivatives.
S. Bosi (2000)
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985).
Zhuyu Xu (2019)
Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus
A. N. Brown (2012)
Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview
H. Liu (2014)
PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Maha Nasr (2014)
Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons
D. Yurek (2009)
Cell Therapeutics in Parkinson’s Disease
O. Lindvall (2011)
Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
A. Kulkarni (2015)
Intravenous glial‐derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter
C. Xia (2008)
Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance
R. Kadam (2012)
Advances in nanomedicines for malaria treatment.
N. P. Aditya (2013)
Helical microtubules of graphitic carbon
S. Iijima (1991)
Regulation of Cell Signaling Factors Using PLGA Nanoparticles Coated/Loaded with Genes and Proteins for Osteogenesis of Human Mesenchymal Stem Cells.
J. Park (2016)
Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration.
Hongwei Gu (2003)
Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans.
Carline Longhi (2016)
Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis
K. Yudoh (2009)
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication
Jonathan Herskovitz (2018)
This paper is referenced by
Gold Nanoparticles as Colorimetric Sensors for the Detection of DNA Bases and Related Compounds
E. Iglesias (2020)
Nanoformulation of lactoferrin potentiates its activity and enhances novel biotechnological applications.
E. El-Fakharany (2020)
Drug Delivery Systems of Natural Products in Oncology.
M. Colone (2020)
Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections
Arturo Sánchez (2020)
Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
D. Ferreira (2020)
Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
Saliha Durak (2020)